Patients recovering from COVID-19 often report symptoms of exhaustion, fatigue and
dyspnoea and present with exercise intolerance persisting for months post-infection …

Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a devastating
inflammatory lung disease with a high mortality rate. ALI/ARDS is induced by various …

Platelet-derived extracellular vesicles (PEVs) are a subset of EVs that are released from
platelets, which are small nuclear cell fragments that play a critical role in hemostasis and …

Introduction Pulmonary diseases represent a significant burden to patients and the
healthcare system and are one of the leading causes of mortality worldwide. Particularly, the …

Considering the spread of the COVID-19 pandemic, finding new drugs along with the
development of effective drug delivery methods can help in the treatment of this disease. For …

SARS-CoV-2 infection can cause severe pneumonia, wherein exacerbated inflammation
plays a major role. This is reminiscent of the process commonly termed cytokine storm, a …

Introduction The Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
infection involves pulmonary inflammation that can progress to acute respiratory distress …

Coronavirus disease-19 (COVID-19), caused by SARS-CoV-2, is a systemic disease that
affects not only the respiratory system, but also other systems, including gastrointestinal. A …

Aims Acute lung inflammation, particularly acute respiratory distress syndrome (ARDS), is
caused by a variety of pathogens including bacteria and viruses. β-Glucans have been …

Dexamethasone (DEX) is a potent synthetic glucocorticoid used for the treatment of variety
of inflammatory and immune-mediated disorders. The RECOVERY clinical trial revealed …